is retatrutide a ped vs Semaglutide and Tirzepatide: GLP-3 Facts explained Retatrutide | Clinician-Reviewed Peptide Therapy

Recent clinical trials (following patients for up to 68 weeks) are showing no significant long-term safety concerns

After a follow-up of 27 months, the researchers reported that just over half of patients (54%) discontinued their prescription for at least 135 days

[DOI] [PMC free article] [PubMed] [Google Scholar] 142.France, N

Smaller meals, low-acid foods, and avoiding known triggers like alcohol, caffeine, and fatty foods can make a real difference without a prescription

This docket runs parallel to existing GLP1 MDL litigation that addresses other injury types, such as gastrointestinal harms

Researchers are now exploring whether this same medication could help people struggling with alcohol and substance dependence and even problem gambling